AptarGroup, Inc. Files 2024 10-K Report

Ticker: ATR · Form: 10-K · Filed: Feb 7, 2025 · CIK: 896622

Aptargroup, INC. 10-K Filing Summary
FieldDetail
CompanyAptargroup, INC. (ATR)
Form Type10-K
Filed DateFeb 7, 2025
Risk Levelmedium
Pages15
Reading Time18 min
Key Dollar Amounts$99 million, $9.4 million, $1.4 million, $1.5 million, $1.2 million
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, financials

TL;DR

APTARGROUP 2024 10-K FILED: FULL FINANCIAL PICTURE NOW AVAILABLE.

AI Summary

AptarGroup, Inc. filed its 2024 10-K report on February 7, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, headquartered in Crystal Lake, IL, operates in the plastics products sector. Key financial data and business operations for the period are outlined in this comprehensive filing.

Why It Matters

This filing provides investors and stakeholders with a detailed overview of AptarGroup's financial health, operational performance, and strategic outlook for the fiscal year 2024.

Risk Assessment

Risk Level: medium — The filing is a standard annual report and does not inherently indicate new or elevated risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of AptarGroup, Inc. as indicated by its SIC code?

AptarGroup, Inc. is classified under 'PLASTICS PRODUCTS, NEC [3089]', indicating its primary business involves plastic products.

When was the 2024 10-K report filed with the SEC?

The 2024 10-K report was filed on February 7, 2025.

What is the fiscal year end date for AptarGroup, Inc.?

The fiscal year end date for AptarGroup, Inc. is December 31.

Where is AptarGroup, Inc. headquartered?

AptarGroup, Inc. is headquartered in Crystal Lake, IL.

What is the SEC Act under which this 10-K filing was made?

This 10-K filing was made under the 1934 Act.

Filing Stats: 4,406 words · 18 min read · ~15 pages · Grade level 14.1 · Accepted 2025-02-07 13:09:41

Key Financial Figures

Filing Documents

Business

Business 1 Item 1A.

Risk Factors

Risk Factors 10 Item 1B. Unresolved Staff Comments 15 Item 1C. Cybersecurity 15 Item 2.

Properties

Properties 17 Item 3.

Legal Proceedings

Legal Proceedings 17 Item 4. Mine Safety Disclosures 17 Part II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 18 Item 6. Reserved 19 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 7A. Quantitative and Qualitative Disclosure about Market Risk 35 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 36 Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 80 Item 9A.

Controls and Procedures

Controls and Procedures 80 Item 9B. Other Information 80 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 80 Part III Item 10. Directors, Executive Officers and Corporate Governance 81 Item 11.

Executive Compensation

Executive Compensation 81 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 81 Item 13. Certain Relationships and Related Transactions, and Director Independence 81 Item 14. Principal Accountant Fees and Services 81 Part IV Item 15. Exhibits and Financial Statement Schedules 82 Item 16. Form 10-K Summary 82 Index of Exhibits 83

Signatures

Signatures 88 i/ATR 2024 Form 10-K Table of Contents PART I

BUSINESS

ITEM 1. BUSINESS WHO ARE WE AND WHAT DO WE DO Aptar is a global leader in the design and manufacturing of drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care, and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world's leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has approximately 13,500 dedicated employees in 20 different countries. For more information, visit www.aptar.com. Our business was started in the late 1940's, manufacturing and selling aerosol valves in the United States, and has grown primarily through acquisitions and organic growth. In this report, we may refer to AptarGroup, Inc. and its subsidiaries as "AptarGroup," "Aptar" or the "Company.". We have manufacturing facilities located throughout the world including North America, Europe, Asia and Latin America. We have approximately 5,000 customers with no single customer or group of affiliated customers accounting for greater than 4% of our 2024 Net Sales. Consumers' and patients' preferences for convenience and product differentiation through drug delivery and packaging design and function are important to our customers and they have converted many of their packages from non-dispensing formats to dispensing systems that offer enhanced shelf appeal, ease of use, convenience, cleanliness and accuracy of dosage. We design our products with both people and the environment in mind. Many of our product solutions for the beauty, personal care, home care, food and beverage markets are recyclable, reusable or made with recycled content and we expect to launch the first fully recyclable pharmaceutical nasal spray. We partner with our cust

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing